Spatial Biology Market - A Global and Regional Analysis: Focus on Molecular Technology, Product Type, Sample Type, Application, and Regional Analysis - Analysis and Forecast, 2025-2035
The global spatial biology market is projected to reach $6,391.1 million by 2035 from $1,649.5 million in 2024, growing at a CAGR of 13.10% during the forecast period 2025-2035.
Epstein Barr Virus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
The global epstein barr virus market is highly competitive, with several key players driving innovation and market growth.
Hemophilia A Market - A Global and Regional Analysis: Focus on Treatment Type, Country, and Region - Analysis and Forecast, 2025-2035
The global hemophilia A market is highly competitive, with several leading companies driving innovation and market growth.
Hepatorenal Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
The Hepatorenal Syndrome Market was valued at $1.7 billion in 2023, driven by rising liver disease complications and growing adoption of HRS-AKI and HRS-CKD therapies.
Need reports on an on-going basis? Do consider our
annual subscription
Single Cell Sample Preparation Market - A Global and Regional Analysis: Focus on Application, Country, and Region - Analysis and Forecast, 2025-2035
The global Single Cell Sample Preparation market is highly competitive, with several key players driving innovation and market growth.
Image-Guided Drug Delivery Market - A Global and Regional Analysis: Focus on Technology Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
The global image-guided drug delivery market is projected to reach $983.0 million by 2035 from $51.4 million in 2024, growing at a CAGR of 31.04% during the forecast period 2025-2035.
Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application, Country, and Region - Analysis and Forecast, 2025-2035
Biobanking refers to the process of collecting, storing, and managing biological samples (such as blood, tissue, DNA, RNA, and other bodily fluids) for research and medical purposes
Residual DNA Testing Market - A Global and Regional Analysis: Focus on Offering, Test Type, Technology, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035
The global Residual DNA Testing market is highly competitive, with several key players driving innovation and market growth.
Cell and Gene Therapy Drug Delivery Market - A Global and Regional Analysis: Focus on Therapy Types, Delivery Methods, Country, and Region - Analysis and Forecast, 2025-2035
The global Cell and Gene Therapy Drug Delivery market, valued at $1.10 Billion in 2023, is growing as advanced methods enable safe delivery of cells and modified genes.
The Common Warts market is expected to continue expanding as new solutions and better patient accessibility are introduced.
The global portal hypertension drugs market is driven by several key factors that are reshaping the landscape of diagnosis, treatment, and patient care.
Agitation in Alzheimer’s Disease refers to a set of symptoms characterized by increased aggression, and emotional instability in patients suffering from Alzheimer's disease.
The global acute bacterial skin and skin structure infection market is growing due to rising infection prevalence, influenced by changing lifestyles and environmental factors.
The global myelofibrosis market grows with advances in JAK inhibitors, improving symptom management, treatment outcomes, and patient quality of life.
Nasal Polyposis are soft, painless, noncancerous growths that develop in the lining of the nose and sinuses, often appearing in clusters and shaped like teardrops.
The global Mucopolysaccharidosis market is fueled by rising demand for effective therapies to manage glycosaminoglycan buildup, prevent organ damage, and improve lives.
EGFR non-small cell lung cancer is caused by mutations in the EGFR gene, leading to uncontrolled cancer cell growth.
Fanconi Anemia is a rare, inherited genetic disorder that primarily affects the bone marrow, leading to a failure in producing adequate blood cells, a condition known as pancytopenia.
Idiopathic pulmonary fibrosis is a progressive lung disease characterized by the gradual scarring (fibrosis) of lung tissue, which impairs the ability of the lungs to function properly.
Liver fibrosis is a progressive disease where scar tissue builds up in the liver due to chronic damage from hepatitis, alcohol use, obesity, or autoimmune conditions.
Coronary microvascular dysfunction (CMD) affects the heart’s small vessels, reducing blood flow and oxygen supply, often occurring without obstructive coronary artery disease.
The cytomegalovirus infection market is driven by the increasing prevalence of CMV infections, especially in high-risk populations such as organ transplant recipients, individuals with HIV/AIDS, and pregnant women.
Facioscapulohumeral muscular dystrophy is a genetic disorder characterized by progressive muscle weakness and degeneration.
The global Dupuytren's disease market is fuelled by rising prevalence, aging populations, increased awareness, and enhanced diagnostic capabilities worldwide.
Dermatomyositis, a rare inflammatory myopathy marked by skin issues and muscle weakness, is gaining recognition globally, driving demand for effective treatment options.
The global familial chylomicronemia syndrome (FCS) market is growing steadily, driven by rising disease awareness, advanced genetic diagnostics, and innovative therapies.
The Pompe disease market is driven by advancements in enzyme replacement therapies, improved diagnostic technologies, & a better understanding of the disease’s pathophysiology.
The Europe flow cytometry market is projected to reach $2,045.7 million by 2035 from $928.3 million in 2024, growing at a CAGR of 7.53% during the forecast period 2025-2035.
The global psoriasis market is driven by innovations in treatment options, increased awareness of dermatological conditions, and the rising prevalence of autoimmune disorders.
The Asia-Pacific flow cytometry market, valued at $747.7 million in 2024, is on a robust growth trajectory and is anticipated to reach $1,919.6 million by 2035.
The cytokine release syndrome market is growing, driven by rising prevalence and increasing use of immunotherapies like CAR T-cell therapies and checkpoint inhibitors.
The global VLU market is expanding, driven by rising chronic conditions, growing awareness, and advancements in wound care technologies.
The ITP market is undergoing steady transformation, driven by increasing disease awareness, innovations in targeted therapies, and a growing emphasis on individualized care strategies.
This growth is primarily driven by the increased awareness of this rare and aggressive soft tissue cancer, primarily affecting adolescents and young adults.
The global ventricular hypertrophy market is driven by the increasing prevalence of cardiovascular diseases, heightened awareness of VH, and advancements in diagnostic and treatment options.
The hunter syndrome market is primarily driven by the rising diagnosis rates, which have been facilitated by advancements in diagnostic technologies such as genetic testing and enzyme activity assays.
The global CAR T-Cell therapy for non-hodgkin’s lymphoma market is driven by a convergence of clinical innovation, rising disease prevalence, and the unmet need for durable treatments in relapsed or refractory cases.
Dyslipidemia, characterized by abnormal levels of lipids such as cholesterol and triglycerides in the blood, significantly elevates the risk of cardiovascular diseases.
The global dystrophic epidermolysis bullosa market is driven by rising awareness, advances in early diagnosis, and improved treatment options.
The global tardive dyskinesia (TD) market is set for steady growth, driven by advancements in novel therapeutics, increasing clinical awareness, and early diagnosis among psychiatric populations.
Growth is driven by rising prevalence, awareness, better diagnostics, and expanding mental health infrastructure, especially in well-equipped regions.
Autism spectrum disorder (ASD) encompasses a broad range of neurodevelopmental conditions characterized by challenges in social interaction, communication, and repetitive behaviours.
The systemic mastocytosis market is driven by the increasing prevalence of KIT gene mutations, enhanced disease awareness, and substantial advancements in targeted therapy and molecular diagnostics.
The global adrenoleukodystrophy market is driven by rising awareness and advancements in gene therapy and innovative drug treatments for better outcomes.
The global cholestatic pruritus market is growing due to rising liver disease cases, increased awareness, and advances in pharmacological and non-drug therapies.
The global spondylolisthesis market is growing due to rising spine disease cases, better awareness, and advances in surgical and non-surgical treatments.
The global cancer cachexia market grows steadily due to rising cancer cases and increased awareness of cachexia as a serious cancer-related complication.
The chronic hand eczema market grows due to rising occupational skin issues, greater dermatology awareness, and advanced treatment options.
The functional dyspepsia market is driven by increased disease awareness, improved diagnostic methods, and advancements in personalized medicine and treatment strategies.
The global cancer pain market is fuelled by the rising prevalence of cancer cases globally and the increasing demand for effective pain management therapies.
The global cancer vaccine market is witnessing significant growth due to rising cancer prevalence, increasing adoption of immunotherapies, and advancements in vaccine development technologies
Leptomeningeal metastases refer to the spread of cancer cells to the leptomeninges—the two innermost layers of tissue covering the brain and spinal cord—and the cerebrospinal fluid.
Leigh syndrome is a rare and severe neurological disorder that primarily affects infants and young children.
Historically, Morquio Syndrome (MPS IV) has been underdiagnosed due to its rarity and symptom overlap with other skeletal disorders.
The Lennox gastaut syndrome market is experiencing significant growth due to the increasing prevalence of the condition, advancements in drug therapies, and the rising recognition of the need for better management options.
The global candidemia market is witnessing significant growth, driven by the rising incidence of candidemia infections and the increasing focus on antifungal drug development.
The global sickle cell disease treatment market is set to grow, driven by rising disease prevalence and demand for effective, accessible therapies.
Stargardt disease, also referred to as Stargardt's macular dystrophy or juvenile macular degeneration is the most prevalent form of macular degeneration in young individuals.
Non-Cystic fibrosis bronchiectasis (NCFB) is a chronic lung condition characterized by the permanent widening and scarring of the bronchi, the airways in the lungs.
The global acute on chronic liver failure market is driven by the rising prevalence of liver diseases like cirrhosis and chronic hepatitis, which are the primary causes of acute on chronic liver failure.
Key factors driving this market include the increasing incidence of brain cancer, advancements in medical technology, and the growing focus on personalized medicine.
The global alagille syndrome market is expected to grow at a significant rate due to developments in targeted therapies, rising awareness and diagnosis, and a growing clinical pipeline, alongside advancements in healthcare infrastructure and access to specialized treatments.
The Messenger RNA Market growth is supported by significant investments from both public and private sectors, accelerating research and development in mRNA technology.
The market for Adult T-cell leukemia/Lymphoma is growing with increased adoption of immunotherapies like CAR-T cell therapies, alongside chemotherapy and stem cell transplants.
The global gene therapy in ophthalmology market is on track for continued growth, driven by the aging population, rising prevalence of genetic ocular disorders, and technological advancements in gene editing and delivery.
The Diabetic Peripheral Neuropathy (DPN) treatment market is experiencing rapid transformation, fueled by advancements in pharmacological therapies, medical devices, and emerging treatment innovations.
The Aicardi-Goutières syndrome market is in early development, with no approved treatments and ongoing research focused on genetics and targeted therapy development.
The High-Grade Glioma market is witnessing transformative trends fueled by advancements in personalized medicine, immunotherapy, and targeted therapies.
The global epilepsy drugs market is driven by the increasing prevalence of epilepsy, ongoing advancements in drug development, and heightened awareness of neurological disorders.
The global acute lymphocytic leukemia market is driven by advancements in treatment options, particularly in chemotherapy, targeted therapies, and immunotherapy.
The Point-of-Care (PoC) Cell and Gene Therapy Manufacturing Market is projected to grow significantly driven by key advancements in automation, decentralized manufacturing, and personalized medicine.
This report provides an in-depth market analysis, covering segmentation by application, technology, product, end-user, and geography.
Softgel capsules are a preferred dosage form for liquid or semi-solid substances, offering several benefits including ease of swallowing, precise dosing, improved bioavailability, and protection of sensitive ingredients from environmental degradation.
The global specialty excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations.
The empty capsules are primarily used for encapsulating powdered and granular substances. These capsules, typically made from gelatin or vegetable-based materials, offer an effective delivery system for medications, vitamins, and other supplements.
The global excipients market for topical pharmaceuticals is growing, driven by demand for effective dermatological treatments and cosmeceuticals.
The liquid-filled capsules market is rapidly evolving, characterized by the growing preference for innovative delivery systems in the pharmaceutical and nutraceutical sectors.
The Hybrid Medicine market is quickly gaining traction as healthcare providers increasingly look to combine conventional treatments with alternative therapies for more comprehensive patient care.
The Cell Line Characterization Market Report provides a comprehensive analysis of the global market, offering valuable insights into the trends, and future prospects of the industry.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The Antibody Hit Generation and Screening Market report covers key segments, competitive landscape, and emerging technologies, offering stakeholders a holistic view of the global market.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
I would like to extend our appreciation for your support in finalizing the report according to our precise needs and prerequisites. I am also impressed by the timely completion of all aspects of dealing with us as your esteemed client. I look forward to continue our professional relations in the future.
Manager-Strategy & Business DevelopmentICL Industrial Products
“I found the content quite interesting and insightful. It has provided us with some important information”
Strategic Insights COE ManagerJapan Tobacco International
I appreciate the extra effort that team BIS took to cater to our specific requirements, moreover, their response time and adaptability is at par with my expectation.
CEO & ChairmanTEKNA Plasma Systems
“BIS research has been a great support to our strategic investigation in the field of thermoplastic composite. BIS did manage to bring together a clear picture on a global level, supported by examples and references and they delivered an accurate evaluation of the current market size and potential in the coming years in line with our expectations. I warmly recommend them.”
VPFuture Business and Innovation